Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical Trial

IMPORTANCE: There are few published studies prospectively assessing pharmacological interventions that may delay prostate cancer progression in patients undergoing active surveillance (AS). OBJECTIVE: To compare the efficacy and safety of enzalutamide monotherapy plus AS vs AS alone in patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Shore, Neal D., Renzulli, Joseph, Fleshner, Neil E., Hollowell, Courtney M. P., Vourganti, Srinivas, Silberstein, Jonathan, Siddiqui, Rizwan, Hairston, John, Elsouda, Dina, Russell, David, Cooperberg, Matthew R., Tomlins, Scott A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204619/
https://www.ncbi.nlm.nih.gov/pubmed/35708696
http://dx.doi.org/10.1001/jamaoncol.2022.1641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204619/
https://www.ncbi.nlm.nih.gov/pubmed/35708696
http://dx.doi.org/10.1001/jamaoncol.2022.1641

Ejemplares similares